Michael R. Pranzatelli
National Pediatric Myoclonus Center and Neuroimmunology Laboratory
Southern Illinois University School of Medicine
Springfield
Illinois; Department of Neurology
Illinois
Name/email consistency: high
- Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus. Pranzatelli, M.R., Tate, E.D., Shenoy, S., Travelstead, A.L. Pediatr. Blood. Cancer (2011)
- Chemokine/cytokine profiling after rituximab: reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Verhulst, S.J. Cytokine (2011)
- Pediatric dosing of rituximab revisited: serum concentrations in opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Verhulst, S.J., Bertolone, S.J., Bhatla, D., Granger, M., Lebowizc, J., Lockhart, S.K., Wiley, J.M. J. Pediatr. Hematol. Oncol. (2010)
- B cell depletion therapy for new-onset opsoclonus-myoclonus. Pranzatelli, M.R., Tate, E.D., Swan, J.A., Travelstead, A.L., Colliver, J.A., Verhulst, S.J., Crosley, C.J., Graf, W.D., Joseph, S.A., Kelfer, H.M., Raju, G.P. Mov. Disord. (2010)
- Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Colliver, J.A. J. Clin. Immunol. (2010)
- Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Baumgardner, C.A., Gowda, N.V., Halthore, S.N., Kerstan, P., Kossak, B.D., Mitchell, W.G., Taub, J.W. J. Child Neurol. (2009)
- Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Crowley, J.M., Toennies, B., Creer, M. Neuropediatrics (2008)
- Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Hoefgen, E.R., Swan, J.A., Colliver, J.A. Cytokine (2008)
- Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. Pranzatelli, M.R., Tate, E.D., Travelstead, A.L., Barbosa, J., Bergamini, R.A., Civitello, L., Franz, D.N., Greffe, B.S., Hanson, R.D., Hurwitz, C.A., Kalinyak, K.A., Kelfer, H., Khakoo, Y., Mantovani, J.F., Nicholson, S.H., Sanders, J.M., Wegner, S. J. Pediatr. Hematol. Oncol. (2006)
- Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone. Pranzatelli, M.R., Tate, E.D., Dukart, W.S., Flint, M.J., Hoffman, M.T., Oksa, A.E. J. Pediatr. (2005)
- B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Pranzatelli, M.R., Travelstead, A.L., Tate, E.D., Allison, T.J., Moticka, E.J., Franz, D.N., Nigro, M.A., Parke, J.T., Stumpf, D.A., Verhulst, S.J. Neurology (2004)
- CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Pranzatelli, M.R., Travelstead, A.L., Tate, E.D., Allison, T.J., Verhulst, S.J. Mov. Disord. (2004)
- Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus. Pranzatelli, M.R., Travelstead, A.L., Tate, E.D., Allison, T.J., Lee, N.D., Fisher, J., Jasty, R. J. Pediatr. Hematol. Oncol. (2004)
- Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG. Pranzatelli, M.R., Tate, E.D., Kinsbourne, M., Caviness, V.S., Mishra, B. Mov. Disord. (2002)